Elite Pharmaceuticals Inc (OTCQB:ELTP)

0.253
Delayed Data
As of Mar 05
 -0.0021 / -0.82%
Today’s Change
0.17
Today|||52-Week Range
0.97
+11.95%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2013
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Revenue and IncomeNet Revenues1.7M1.0M1.2M1.3M
 
 
 
 
 
Cost of Goods Sold994.6K1.0M713.0K681.7K
 
 
 
 
 
Depreciation And Amortization126.8K128.7K209.4K276.8K
 
 
 
 
 
 
Operating ExpensesGross Income571.8K-147.0K239.3K297.9K
 
 
 
 
 
General Expenses1.8M2.2M4.7M4.4M
 
 
 
 
 
Research And Development1.3M1.2M4.0M3.6M
 
 
 
 
 
Total Operating Expenses2.9M3.4M5.6M5.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.2M-2.4M-4.4M-4.1M
 
 
 
 
 
Extraordinary Credit533.8K0.00--25.5M
 
 
 
Extraordinary Charge---84.5M-1.6M--
 
 
 
Interest Expense On Debt358.5K169.6K78.2K70.1K
 
 
 
 
 
Other Expenses0.000.001.7M0.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.1M-87.1M-4.4M21.4M
 
 
 
 
 
Income Taxes0.00-294.9K-3.2K0.00
 
 
 
Net Income-1.1M-86.8M-4.4M21.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS508.6M560.1M565.2M577.7M
 
 
 
 
 
Shares To Calculate EPS Diluted508.6M560.1M733.9M739.9M
 
 
 
 
 
 
Earnings Per ShareEPS$0.00-$0.16-$0.01-$0.01
 
 
 
 
EPS Diluted-$0.00-$0.16-$0.01-$0.01
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account